These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
||||
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
|
|
|
|
☒ | No ☐ |
|
☒ | No ☐ |
|
☒ | Accelerated filer | ☐ | Non-accelerated filer | ☐ | Smaller reporting company |
|
Emerging growth company |
|
Yes |
|
No ☒ |
1
|
Page | |||||
No. | |||||
September 30, 2023 and December 31, 2022
|
|||||
Three and nine months ended September 30, 2023 and 2022
|
|||||
Three and nine months ended September 30, 2023 and 2022
|
|||||
Three and nine months ended September 30, 2023 and 2022
|
|||||
Nine months ended September 30, 2023 and 2022
|
|||||
2
|
September 30, | December 31, | ||||||||||
2023 | 2022 | ||||||||||
(Dollar amounts in millions, except per share data) | |||||||||||
Assets: | |||||||||||
Investments: | |||||||||||
Fixed maturities, amortized cost of $
|
$ |
|
$ |
|
|||||||
Equity securities, cost of $
|
|
|
|||||||||
Limited partnership investments |
|
|
|||||||||
Other invested assets, primarily mortgage loans, less allowance for credit loss of $
|
|
|
|||||||||
Short term investments |
|
|
|||||||||
Total investments |
|
|
|||||||||
Cash |
|
|
|||||||||
Receivables |
|
|
|||||||||
Property, plant and equipment |
|
|
|||||||||
Goodwill |
|
|
|||||||||
Deferred non-insurance warranty acquisition expenses |
|
|
|||||||||
Deferred acquisition costs of insurance subsidiaries |
|
|
|||||||||
Other assets |
|
|
|||||||||
Total assets | $ |
|
$ |
|
|||||||
Liabilities and Equity: | |||||||||||
Insurance reserves: | |||||||||||
Claim and claim adjustment expense | $ |
|
$ |
|
|||||||
Future policy benefits |
|
|
|||||||||
Unearned premiums |
|
|
|||||||||
Total insurance reserves |
|
|
|||||||||
Payable to brokers |
|
|
|||||||||
Short term debt |
|
|
|||||||||
Long term debt |
|
|
|||||||||
Deferred income taxes |
|
|
|||||||||
Deferred non-insurance warranty revenue |
|
|
|||||||||
Other liabilities |
|
|
|||||||||
Total liabilities |
|
|
|||||||||
Commitments and contingent liabilities |
|
|
|||||||||
Preferred stock, $
|
|||||||||||
Authorized –
|
|
|
|||||||||
Common stock, $
|
|||||||||||
Authorized –
|
|||||||||||
Issued –
|
|
|
|||||||||
Additional paid-in capital |
|
|
|||||||||
Retained earnings |
|
|
|||||||||
Accumulated other comprehensive loss |
(
|
(
|
|||||||||
|
|
||||||||||
Less treasury stock, at cost (
|
(
|
(
|
|||||||||
Total shareholders’ equity |
|
|
|||||||||
Noncontrolling interests |
|
|
|||||||||
Total equity |
|
|
|||||||||
Total liabilities and equity | $ |
|
$ |
|
3
|
Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||
September 30, | September 30, | |||||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||||||||||||
(In millions, except per share data) | ||||||||||||||||||||||||||
Revenues: | ||||||||||||||||||||||||||
Insurance premiums | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
Net investment income |
|
|
|
|
||||||||||||||||||||||
Investment losses |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Non-insurance warranty revenue |
|
|
|
|
||||||||||||||||||||||
Operating revenues and other |
|
|
|
|
||||||||||||||||||||||
Total |
|
|
|
|
||||||||||||||||||||||
Expenses: | ||||||||||||||||||||||||||
Insurance claims and policyholders’ benefits
(re-measurement loss of $(
|
|
|
|
|
||||||||||||||||||||||
Amortization of deferred acquisition costs |
|
|
|
|
||||||||||||||||||||||
Non-insurance warranty expense |
|
|
|
|
||||||||||||||||||||||
Operating expenses and other |
|
|
|
|
||||||||||||||||||||||
Equity method income |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Interest |
|
|
|
|
||||||||||||||||||||||
Total |
|
|
|
|
||||||||||||||||||||||
Income (loss) before income tax |
|
(
|
|
|
||||||||||||||||||||||
Income tax expense |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Net income (loss) |
|
(
|
|
|
||||||||||||||||||||||
Amounts attributable to noncontrolling interests |
(
|
|
(
|
(
|
||||||||||||||||||||||
Net income (loss) attributable to Loews Corporation | $ |
|
$ |
(
|
$ |
|
$ |
|
||||||||||||||||||
Basic net income (loss) per share | $ |
|
$ |
(
|
$ |
|
$ |
|
||||||||||||||||||
Diluted net income (loss) per share | $ |
|
$ |
(
|
$ |
|
$ |
|
||||||||||||||||||
Weighted average shares outstanding: | ||||||||||||||||||||||||||
Shares of common stock |
|
|
|
|
||||||||||||||||||||||
Dilutive potential shares of common stock |
|
|
|
|
||||||||||||||||||||||
Total weighted average shares outstanding assuming dilution |
|
|
|
|
4
|
Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||
September 30, | September 30, | |||||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||||||||||||
(In millions) | ||||||||||||||||||||||||||
Net income (loss) | $ |
|
$ |
(
|
$ |
|
$ |
|
||||||||||||||||||
Other comprehensive income (loss), after tax | ||||||||||||||||||||||||||
Changes in: | ||||||||||||||||||||||||||
Net unrealized losses on investments with an allowance for credit losses |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Net unrealized losses on other investments |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Total unrealized losses on investments |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Impact of changes in discount rates used to measure long-duration contract liabilities |
|
|
|
|
||||||||||||||||||||||
Unrealized gains (losses) on cash flow hedges |
(
|
|
|
|
||||||||||||||||||||||
Pension and postretirement benefits |
|
|
|
|
||||||||||||||||||||||
Foreign currency translation |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Other comprehensive loss |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Comprehensive income (loss) |
(
|
(
|
|
(
|
||||||||||||||||||||||
Amounts attributable to noncontrolling interests |
|
|
(
|
|
||||||||||||||||||||||
Total comprehensive income (loss) attributable to Loews Corporation | $ |
|
$ |
(
|
$ |
|
$ |
(
|
5
|
Loews Corporation Shareholders | ||||||||||||||||||||||||||||||||||||||||||||||||||
Total | Common Stock | Additional Paid-in Capital | Retained Earnings | Accumulated Other Comprehensive Income (Loss) |
Common Stock
Held in Treasury |
Noncontrolling Interests | ||||||||||||||||||||||||||||||||||||||||||||
(In millions) | ||||||||||||||||||||||||||||||||||||||||||||||||||
Balance, July 1, 2022, as reported
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
||||||||||||||||||||||||||||||||||||
Cumulative effect adjustments from changes in
accounting standards (Note 1) |
(
|
(
|
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||||||
Balance, July 1, 2022, as adjusted
|
|
|
|
|
(
|
(
|
|
|||||||||||||||||||||||||||||||||||||||||||
Net loss |
(
|
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||||
Other comprehensive loss |
(
|
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||||
Dividends paid ($
|
(
|
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||||
Purchase of subsidiary stock from noncontrolling interests |
(
|
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||||
Purchases of Loews Corporation treasury stock |
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||||||||
Stock-based compensation |
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||
Other |
|
|
(
|
|
||||||||||||||||||||||||||||||||||||||||||||||
Balance, September 30, 2022
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
||||||||||||||||||||||||||||||||||||
Balance, July 1, 2023
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
||||||||||||||||||||||||||||||||||||
Net income |
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||
Other comprehensive income (loss) |
(
|
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||||
Dividends paid ($
|
(
|
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||||
Purchase of subsidiary stock from noncontrolling interests |
(
|
|
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||||||
Purchases of Loews Corporation treasury stock |
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||||||||
Stock-based compensation |
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||
Other |
|
(
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||
Balance, September 30, 2023
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
6
|
Loews Corporation Shareholders | ||||||||||||||||||||||||||||||||||||||||||||||||||
Total | Common Stock | Additional Paid-in Capital | Retained Earnings | Accumulated Other Comprehensive Income (Loss) |
Common Stock
Held in Treasury |
Noncontrolling Interests | ||||||||||||||||||||||||||||||||||||||||||||
(In millions) | ||||||||||||||||||||||||||||||||||||||||||||||||||
Balance, January 1, 2022, as reported
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
||||||||||||||||||||||||||||||||||||
Cumulative effect adjustments from changes in
accounting standards (Note 1) |
(
|
(
|
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||||||
Balance, January 1, 2022, as adjusted
|
|
|
|
|
(
|
(
|
|
|||||||||||||||||||||||||||||||||||||||||||
Net income |
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||
Other comprehensive loss |
(
|
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||||
Dividends paid ($
|
(
|
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||||
Purchase of subsidiary stock from noncontrolling interests |
(
|
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||||
Purchases of Loews Corporation treasury stock |
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||||||||
Stock-based compensation |
|
(
|
|
|||||||||||||||||||||||||||||||||||||||||||||||
Other |
|
|
(
|
|
||||||||||||||||||||||||||||||||||||||||||||||
Balance, September 30, 2022
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
||||||||||||||||||||||||||||||||||||
Balance, January 1, 2023, as reported
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
||||||||||||||||||||||||||||||||||||
Cumulative effect adjustments from changes in
accounting standards (Note 1) |
(
|
(
|
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||||||
Balance, January 1, 2023, as adjusted
|
|
|
|
|
(
|
(
|
|
|||||||||||||||||||||||||||||||||||||||||||
Net income |
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||
Other comprehensive income (loss) |
(
|
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||||
Dividends paid ($
|
(
|
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||||
Purchase of subsidiary stock from noncontrolling interests |
(
|
|
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||||||
Purchases of Loews Corporation treasury stock |
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||||||||
Stock-based compensation |
|
(
|
|
|||||||||||||||||||||||||||||||||||||||||||||||
Other |
(
|
(
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||
Balance, September 30, 2023
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
7
|
Nine Months Ended September 30
|
2023 | 2022 | |||||||||
(In millions) | |||||||||||
Operating Activities: | |||||||||||
Net income | $ |
|
$ |
|
|||||||
Adjustments to reconcile net income to net cash provided by operating activities, net |
|
|
|||||||||
Changes in operating assets and liabilities, net: | |||||||||||
Receivables |
(
|
(
|
|||||||||
Deferred acquisition costs |
(
|
(
|
|||||||||
Insurance reserves |
|
|
|||||||||
Other assets |
(
|
(
|
|||||||||
Other liabilities |
|
|
|||||||||
Trading securities |
|
|
|||||||||
Net cash flow provided by operating activities |
|
|
|||||||||
Investing Activities: | |||||||||||
Purchases of fixed maturities |
(
|
(
|
|||||||||
Proceeds from sales of fixed maturities |
|
|
|||||||||
Proceeds from maturities of fixed maturities |
|
|
|||||||||
Purchases of equity securities |
(
|
(
|
|||||||||
Proceeds from sales of equity securities |
|
|
|||||||||
Purchases of limited partnership investments |
(
|
(
|
|||||||||
Proceeds from sales of limited partnership investments |
|
|
|||||||||
Purchases of property, plant and equipment |
(
|
(
|
|||||||||
Acquisitions |
(
|
|
|||||||||
Dispositions |
|
|
|||||||||
Investment in Altium Packaging |
|
(
|
|||||||||
Change in short term investments |
|
|
|||||||||
Other, net |
(
|
|
|||||||||
Net cash flow used by investing activities |
(
|
(
|
|||||||||
Financing Activities: | |||||||||||
Dividends paid |
(
|
(
|
|||||||||
Dividends paid to noncontrolling interests |
(
|
(
|
|||||||||
Purchases of Loews Corporation treasury stock |
(
|
(
|
|||||||||
Purchases of subsidiary stock from noncontrolling interests |
(
|
(
|
|||||||||
Principal payments on debt |
(
|
(
|
|||||||||
Issuance of debt |
|
|
|||||||||
Other, net |
(
|
(
|
|||||||||
Net cash flow used by financing activities |
(
|
(
|
|||||||||
Effect of foreign exchange rate on cash |
|
(
|
|||||||||
Net change in cash |
|
|
|||||||||
Cash, beginning of period |
|
|
|||||||||
Cash, end of period | $ |
|
$ |
|
8
|
9
|
(In millions) | |||||
Balance as of December 31, 2020, as reported | $ |
|
|||
Reclassification of reserves for policyholders currently receiving benefits to Future policy benefits
(a)
|
|
||||
De-recognition of shadow reserves |
(
|
||||
Re-measurement using an upper-medium grade fixed income instrument yield discount rate |
|
||||
Other adjustments
|
|
||||
Balance as of January 1, 2021, as adjusted | $ |
|
(a) |
In conjunction with the adoption of
ASU 2018-12
, at January 1, 2023, the long term care reserves for policyholders currently receiving benefits were reclassified from Claim and claim adjustment expense to Future policy benefits. This change was applied retrospectively as of January 1, 2021.
|
10
|
Accumulated other comprehensive income (loss) | Retained earnings | Noncontrolling interests | |||||||||||||||
(In millions) | |||||||||||||||||
Balance as of December 31, 2020, as reported | $ |
|
$ |
|
$ |
|
|||||||||||
De-recognition of shadow reserves |
|
|
|
||||||||||||||
Re-measurement of LFPB using an upper-medium grade fixed
income instrument yield discount rate |
(
|
|
(
|
||||||||||||||
Other adjustments |
|
(
|
(
|
||||||||||||||
Balance as of January 1, 2021, as adjusted | $ |
(
|
$ |
|
$ |
|
Three Months Ended September 30, 2022 | As Reported | Effect of Adoption | As Adjusted | ||||||||||||||
(In millions) | |||||||||||||||||
Insurance claims and policyholders’ benefits (a) | $ |
|
$ |
|
$ |
|
|||||||||||
Income (loss) before income tax |
|
(
|
(
|
||||||||||||||
Income tax expense |
(
|
|
(
|
||||||||||||||
Net income (loss) |
|
(
|
(
|
||||||||||||||
Amounts attributable to noncontrolling interests |
(
|
|
|
||||||||||||||
Net income (loss) attributable to Loews Corporation |
|
(
|
(
|
||||||||||||||
Basic net income (loss) per share |
|
(
|
(
|
||||||||||||||
Diluted net income (loss) per share |
|
(
|
(
|
(a) |
The effect of adopting ASU 2018-12 on Insurance claims and policyholders’ benefits is inclusive of the re-measurement loss of $
|
Nine Months Ended September 30, 2022 | As Reported | Effect of Adoption | As Adjusted | ||||||||||||||
(In millions) | |||||||||||||||||
Insurance claims and policyholders’ benefits (a) | $ |
|
$ |
|
$ |
|
|||||||||||
Income before income tax |
|
(
|
|
||||||||||||||
Income tax expense |
(
|
|
(
|
||||||||||||||
Net income |
|
(
|
|
||||||||||||||
Amounts attributable to noncontrolling interests |
(
|
|
(
|
||||||||||||||
Net income attributable to Loews Corporation |
|
(
|
|
||||||||||||||
Basic net income per share |
|
(
|
|
||||||||||||||
Diluted net income per share |
|
(
|
|
(a) |
The effect of adopting ASU 2018-12 on Insurance claims and policyholders’ benefits is inclusive of the re-measurement loss of $
|
11
|
December 31, 2022 | As Reported | Effect of Adoption | As Adjusted | ||||||||||||||
(In millions) | |||||||||||||||||
Other assets | $ |
|
$ |
|
$ |
|
|||||||||||
Total assets |
|
|
|
||||||||||||||
Claim and claim adjustment expenses (a) |
|
(
|
|
||||||||||||||
Future policy benefits (a) |
|
|
|
||||||||||||||
Total liabilities |
|
|
|
||||||||||||||
Retained earnings |
|
(
|
|
||||||||||||||
Accumulated other comprehensive income (loss) |
(
|
(
|
(
|
||||||||||||||
Noncontrolling interests |
|
(
|
|
||||||||||||||
Total equity |
|
(
|
|
(a) |
In conjunction with the adoption of ASU 2018-12, at January 1, 2023, the long term care reserves for policyholders currently receiving benefits were reclassified from Claim and claim adjustment expense to Future policy benefits. This change was applied retrospectively as of January 1, 2021.
|
Three Months Ended September 30, 2022 | As Reported | Effect of Adoption | As Adjusted | ||||||||||||||
(In millions) | |||||||||||||||||
Changes in: Net unrealized losses on other investments | $ |
(
|
$ |
(
|
$ |
(
|
|||||||||||
Total unrealized losses on investments |
(
|
(
|
(
|
||||||||||||||
Impact of changes in discount rates used to measure long-duration
contract liabilities |
|
|
|||||||||||||||
Other comprehensive (loss) |
(
|
|
(
|
||||||||||||||
Comprehensive (loss) |
(
|
|
(
|
||||||||||||||
Amounts attributable to noncontrolling interests |
|
(
|
|
||||||||||||||
Total comprehensive (loss) attributable to Loews Corporation |
(
|
|
(
|
Nine Months Ended September 30, 2022 | As Reported | Effect of Adoption | As Adjusted | ||||||||||||||
(In millions) | |||||||||||||||||
Changes in: Net unrealized losses on other investments | $ |
(
|
$ |
(
|
$ |
(
|
|||||||||||
Total unrealized losses on investments |
(
|
(
|
(
|
||||||||||||||
Impact of changes in discount rates used to measure long-duration
contract liabilities |
|
|
|||||||||||||||
Other comprehensive (loss) |
(
|
|
(
|
||||||||||||||
Comprehensive (loss) |
(
|
|
(
|
||||||||||||||
Amounts attributable to noncontrolling interests |
|
(
|
|
||||||||||||||
Total comprehensive (loss) attributable to Loews Corporation |
(
|
|
(
|
12
|
Nine Months Ended September 30, 2022 | As Reported | Effect of Adoption | As Adjusted | ||||||||||||||
(In millions) | |||||||||||||||||
Net income | $ |
|
$ |
(
|
$ |
|
|||||||||||
Adjustments to reconcile net income to net cash provided by operating
activities, net |
|
(
|
|
||||||||||||||
Changes in: Insurance reserves |
|
|
|
Three Months Ended September 30, 2022 | As Reported | Effect of Adoption | As Adjusted | ||||||||||||||
(In millions) | |||||||||||||||||
Insurance claims and policyholders’ benefits (a) | $ |
|
$ |
|
$ |
|
|||||||||||
Income (loss) before income tax |
|
(
|
(
|
||||||||||||||
Income tax (expense) benefit |
(
|
|
|
||||||||||||||
Net income (loss) |
|
(
|
(
|
||||||||||||||
Amounts attributable to noncontrolling interests |
(
|
|
|
||||||||||||||
Net income (loss) attributable to Loews Corporation |
|
(
|
(
|
(a) |
The effect of adopting ASU 2018-12 on Insurance claims and policyholders’ benefits is inclusive of the re-measurement loss of $
|
Nine Months Ended September 30, 2022 | As Reported | Effect of Adoption | As Adjusted | ||||||||||||||
(In millions) | |||||||||||||||||
Insurance claims and policyholders’ benefits (a) | $ |
|
$ |
|
$ |
|
|||||||||||
Income before income tax |
|
(
|
|
||||||||||||||
Income tax expense |
(
|
|
(
|
||||||||||||||
Net income |
|
(
|
|
||||||||||||||
Amounts attributable to noncontrolling interests |
(
|
|
(
|
||||||||||||||
Net income attributable to Loews Corporation |
|
(
|
|
(a) |
The effect of adopting ASU 2018-12 on Insurance claims and policyholders’ benefits is inclusive of the re-measurement loss of $
|
13
|
Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||
September 30, | September 30, | |||||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||||||||||||
(In millions) | ||||||||||||||||||||||||||
Fixed maturity securities | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
Limited partnership investments |
|
(
|
|
(
|
||||||||||||||||||||||
Short term investments |
|
|
|
|
||||||||||||||||||||||
Equity securities (a) |
|
|
|
(
|
||||||||||||||||||||||
Income (loss) from trading portfolio (a) |
|
(
|
|
(
|
||||||||||||||||||||||
Other |
|
|
|
|
||||||||||||||||||||||
Total investment income |
|
|
|
|
||||||||||||||||||||||
Investment expenses |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Net investment income | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
(a) Net investment income (loss) recognized due to the change in fair value of equity and trading portfolio securities held as of September 30, 2023 and 2022
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
14
|
Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||
September 30, | September 30, | |||||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||||||||||||
(In millions) | ||||||||||||||||||||||||||
Fixed maturity securities: | ||||||||||||||||||||||||||
Gross gains | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
Gross losses |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Investment losses on fixed maturity securities |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Equity securities (a) |
|
(
|
(
|
(
|
||||||||||||||||||||||
Derivative instruments |
|
|
|
|
||||||||||||||||||||||
Short term investments and other |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Gain on acquisition of a joint venture (see Note 2) |
|
|||||||||||||||||||||||||
Investment losses | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||
(a) Investment gains (losses) recognized due to the change in fair value of non-redeemable preferred stock included within equity securities held as of September 30, 2023 and 2022
|
$ |
|
$ |
(
|
$ |
|
$ |
(
|
Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||
September 30, | September 30, | |||||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||||||||||||
(In millions) | ||||||||||||||||||||||||||
Fixed maturity securities available-for-sale: | ||||||||||||||||||||||||||
Corporate and other bonds | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
Asset-backed |
|
|
|
|
||||||||||||||||||||||
Impairment losses recognized in earnings | $ |
|
$ |
|
$ |
|
$ |
|
15
|
September 30, 2023 | Cost or Amortized Cost |
Gross Unrealized
Gains |
Gross Unrealized
Losses |
Allowance
for Credit Losses |
Estimated
Fair Value |
||||||||||||||||||||||||
(In millions) | |||||||||||||||||||||||||||||
Fixed maturity securities: | |||||||||||||||||||||||||||||
Corporate and other bonds | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||
States, municipalities and political
subdivisions |
|
|
|
|
|
||||||||||||||||||||||||
Asset-backed: | |||||||||||||||||||||||||||||
Residential mortgage-backed |
|
|
|
|
|
||||||||||||||||||||||||
Commercial mortgage-backed |
|
|
|
|
|
||||||||||||||||||||||||
Other asset-backed |
|
|
|
|
|
||||||||||||||||||||||||
Total asset-backed |
|
|
|
|
|
||||||||||||||||||||||||
U.S. Treasury and obligations of
government sponsored enterprises |
|
|
|
|
|
||||||||||||||||||||||||
Foreign government |
|
|
|
|
|
||||||||||||||||||||||||
Fixed maturities available-for-sale | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||
Fixed maturities trading |
|
|
|
|
|
||||||||||||||||||||||||
Total fixed maturity securities | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
December 31, 2022 | |||||||||||||||||||||||||||||
Fixed maturity securities: | |||||||||||||||||||||||||||||
Corporate and other bonds | $ |
|
$ |
|
$ |
|
|
$ |
|
||||||||||||||||||||
States, municipalities and political
subdivisions |
|
|
|
|
|
||||||||||||||||||||||||
Asset-backed: | |||||||||||||||||||||||||||||
Residential mortgage-backed |
|
|
|
|
|
||||||||||||||||||||||||
Commercial mortgage-backed |
|
|
|
|
|
||||||||||||||||||||||||
Other asset-backed |
|
|
|
$ |
|
|
|||||||||||||||||||||||
Total asset-backed |
|
|
|
|
|
||||||||||||||||||||||||
U.S. Treasury and obligations of
government sponsored enterprises |
|
|
|
|
|
||||||||||||||||||||||||
Foreign government |
|
|
|
|
|
||||||||||||||||||||||||
Redeemable preferred stock |
|
|
|
|
|
||||||||||||||||||||||||
Fixed maturities available-for-sale | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||
Fixed maturities trading |
|
|
|
|
|
||||||||||||||||||||||||
Total fixed maturity securities | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
16
|
Less than 12 Months | 12 Months or Longer | Total | |||||||||||||||||||||||||||||||||
September 30, 2023 | Estimated Fair Value | Gross Unrealized Losses | Estimated Fair Value | Gross Unrealized Losses | Estimated Fair Value | Gross Unrealized Losses | |||||||||||||||||||||||||||||
(In millions) | |||||||||||||||||||||||||||||||||||
Fixed maturity securities: | |||||||||||||||||||||||||||||||||||
Corporate and other bonds | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||
States, municipalities and political
subdivisions |
|
|
|
|
|
|
|||||||||||||||||||||||||||||
Asset-backed: | |||||||||||||||||||||||||||||||||||
Residential mortgage-backed |
|
|
|
|
|
|
|||||||||||||||||||||||||||||
Commercial mortgage-backed |
|
|
|
|
|
|
|||||||||||||||||||||||||||||
Other asset-backed |
|
|
|
|
|
|
|||||||||||||||||||||||||||||
Total asset-backed |
|
|
|
|
|
|
|||||||||||||||||||||||||||||
U.S. Treasury and obligations of
government-sponsored enterprises |
|
|
|
|
|
|
|||||||||||||||||||||||||||||
Foreign government |
|
|
|
|
|
|
|||||||||||||||||||||||||||||
Total fixed maturity securities | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||
December 31, 2022 | |||||||||||||||||||||||||||||||||||
Fixed maturity securities: | |||||||||||||||||||||||||||||||||||
Corporate and other bonds | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||
States, municipalities and political
subdivisions |
|
|
|
|
|
|
|||||||||||||||||||||||||||||
Asset-backed: | |||||||||||||||||||||||||||||||||||
Residential mortgage-backed |
|
|
|
|
|
|
|||||||||||||||||||||||||||||
Commercial mortgage-backed |
|
|
|
|
|
|
|||||||||||||||||||||||||||||
Other asset-backed |
|
|
|
|
|
|
|||||||||||||||||||||||||||||
Total asset-backed |
|
|
|
|
|
|
|||||||||||||||||||||||||||||
U.S. Treasury and obligations of
government-sponsored enterprises |
|
|
|
|
|
|
|||||||||||||||||||||||||||||
Foreign government |
|
|
|
|
|
|
|||||||||||||||||||||||||||||
Total fixed maturity securities | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
17
|
September 30, 2023 | December 31, 2022 | ||||||||||||||||||||||
Estimated Fair Value | Gross Unrealized Losses | Estimated Fair Value | Gross Unrealized Losses | ||||||||||||||||||||
(In millions) | |||||||||||||||||||||||
U.S. Government, Government agencies and Government-sponsored enterprises | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
AAA |
|
|
|
|
|||||||||||||||||||
AA |
|
|
|
|
|||||||||||||||||||
A |
|
|
|
|
|||||||||||||||||||
BBB |
|
|
|
|
|||||||||||||||||||
Non-investment grade |
|
|
|
|
|||||||||||||||||||
Total | $ |
|
$ |
|
$ |
|
$ |
|
18
|
Three months ended September 30, 2023 |
Corporate and Other Bonds
|
Asset-backed |
Total
|
||||||||||||||
(In millions) | |||||||||||||||||
Allowance for credit losses: | |||||||||||||||||
Balance as of July 1, 2023
|
$ |
|
$ |
|
$ |
|
|||||||||||
Additions to the allowance for credit losses: | |||||||||||||||||
Securities for which credit losses were not previously recorded |
|
|
|
||||||||||||||
Available-for-sale securities accounted for as PCD assets |
|
|
|
||||||||||||||
Reductions to the allowance for credit losses: | |||||||||||||||||
Write-offs charged against the allowance |
|
|
|
||||||||||||||
Additional increases to the allowance for credit losses
on securities that had an allowance recorded in a previous period
|
|
|
|
||||||||||||||
Total allowance for credit losses | $ |
|
$ |
|
$ |
|
Three months ended September 30, 2022 | Corporate and Other Bonds | Asset-backed | Total | ||||||||||||||
(In millions) | |||||||||||||||||
Allowance for credit losses: | |||||||||||||||||
Balance as of July 1, 2022
|
$ |
|
$ |
|
$ |
|
|||||||||||
Additional decreases to the allowance for credit losses
on securities that had an allowance recorded in a previous period
|
|
(
|
(
|
||||||||||||||
Total allowance for credit losses | $ |
|
$ |
|
$ |
|
Nine months ended September 30, 2023 | |||||||||||||||||
Allowance for credit losses: | |||||||||||||||||
Balance as of January 1, 2023
|
$ |
|
$ |
|
$ |
|
|||||||||||
Additions to the allowance for credit losses: | |||||||||||||||||
Securities for which credit losses were not previously recorded |
|
|
|
||||||||||||||
Available-for-sale securities accounted for as PCD assets |
|
|
|
||||||||||||||
Reductions to the allowance for credit losses: | |||||||||||||||||
Securities sold during the period (realized) |
|
|
|
||||||||||||||
Intent to sell or more likely than not will be required to sell the security before recovery of its amortized cost basis |
|
|
|
||||||||||||||
Write-offs charged against the allowance |
|
|
|
||||||||||||||
Additional increases to the allowance for credit
losses on securities that had an allowance recorded in a previous period
|
|
|
|
||||||||||||||
Total allowance for credit losses | $ |
|
$ |
|
$ |
|
19
|
Nine months ended September 30, 2022 | |||||||||||||||||
Allowance for credit losses: | |||||||||||||||||
Balance as of January 1, 2022
|
$ |
|
$ |
|
$ |
|
|||||||||||
Additions to the allowance for credit losses: | |||||||||||||||||
Available-for-sale securities accounted for as PCD assets |
|
|
|
||||||||||||||
Reductions to the allowance for credit losses: | |||||||||||||||||
Write-offs charged against the allowance |
|
|
|
||||||||||||||
Additional increases or (decreases) to the allowance for credit losses
on securities that had an allowance recorded in a previous period
|
|
(
|
(
|
||||||||||||||
Total allowance for credit losses | $ |
|
$ |
|
$ |
|
September 30, 2023 | December 31, 2022 | ||||||||||||||||||||||
Cost or Amortized Cost |
Estimated Fair
Value |
Cost or Amortized Cost |
Estimated
Fair Value |
||||||||||||||||||||
(In millions) | |||||||||||||||||||||||
Due in one year or less | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Due after one year through five years |
|
|
|
|
|||||||||||||||||||
Due after five years through ten years |
|
|
|
|
|||||||||||||||||||
Due after ten years |
|
|
|
|
|||||||||||||||||||
Total | $ |
|
$ |
|
$ |
|
$ |
|
20
|
Mortgage Loans Amortized Cost Basis by Origination Year
(a)
|
|||||||||||||||||||||||||||||||||||||||||
As of September 30, 2023
|
2023
|
2022
|
2021
|
2020
|
2019
|
Prior | Total | ||||||||||||||||||||||||||||||||||
(In millions) | |||||||||||||||||||||||||||||||||||||||||
DSCR ≥1.6x | |||||||||||||||||||||||||||||||||||||||||
LTV less than 55% |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||
LTV 55% to 65% |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
LTV greater than 65% |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
DSCR 1.2x - 1.6x | |||||||||||||||||||||||||||||||||||||||||
LTV less than 55% | $ |
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||
LTV 55% to 65% |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
LTV greater than 65% |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
DSCR ≤1.2x | |||||||||||||||||||||||||||||||||||||||||
LTV less than 55% |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
LTV 55% to 65% |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
LTV greater than 65% |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
Total | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
(a) | The values in the table above reflect DSCR on a standardized amortization period and LTV ratios based on the most recent appraised values trended forward using changes in a commercial real estate price index. |
September 30, 2023 | December 31, 2022 | ||||||||||||||||||||||||||||||||||
Contractual/Notional Amount | Estimated Fair Value | Contractual/Notional Amount | Estimated Fair Value | ||||||||||||||||||||||||||||||||
Asset |
(Liability)
|
Asset | (Liability) | ||||||||||||||||||||||||||||||||
(In millions) | |||||||||||||||||||||||||||||||||||
Without hedge designation: | |||||||||||||||||||||||||||||||||||
Equity markets: | |||||||||||||||||||||||||||||||||||
Options – purchased | $ |
|
$ |
|
|
|
|
|
|||||||||||||||||||||||||||
Futures – short |
|
|
|
$ |
|
|
|
||||||||||||||||||||||||||||
Warrants |
|
|
|
|
$ |
|
|
||||||||||||||||||||||||||||
Interest rate swaps |
|
|
|
|
|
|
|||||||||||||||||||||||||||||
Currency forwards |
|
|
$ |
(
|
|
|
$ |
(
|
|||||||||||||||||||||||||||
21
|
September 30, 2023 |
Level 1
|
Level 2
|
Level 3 |
Total
|
|||||||||||||||||||
(In millions) | |||||||||||||||||||||||
Fixed maturity securities: | |||||||||||||||||||||||
Corporate bonds and other | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
States, municipalities and political subdivisions |
|
|
|
|
|||||||||||||||||||
Asset-backed |
|
|
|
|
|||||||||||||||||||
Fixed maturities available-for-sale |
|
|
|
|
|||||||||||||||||||
Fixed maturities trading |
|
|
|
|
|||||||||||||||||||
Total fixed maturities | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Equity securities | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Short term and other |
|
|
|
|
|||||||||||||||||||
Receivables |
|
|
|
|
|||||||||||||||||||
Payable to brokers |
(
|
|
|
(
|
|||||||||||||||||||
December 31, 2022 | |||||||||||||||||||||||
Fixed maturity securities: | |||||||||||||||||||||||
Corporate bonds and other | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
States, municipalities and political subdivisions |
|
|
|
|
|||||||||||||||||||
Asset-backed |
|
|
|
|
|||||||||||||||||||
Fixed maturities available-for-sale |
|
|
|
|
|||||||||||||||||||
Fixed maturities trading |
|
|
|
|
|||||||||||||||||||
Total fixed maturities | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Equity securities | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Short term and other |
|
|
|
|
|||||||||||||||||||
Receivables |
|
|
|
|
|||||||||||||||||||
Payable to brokers |
(
|
|
|
(
|
22
|
Net Realized Investment Gains (Losses) and Net Change in Unrealized Investment Gains (Losses) |
Unrealized Gains (Losses) Recognized in Net Income (Loss) on Level 3 Assets and Liabilities Held at September 30
|
Unrealized Gains (Losses) Recognized in Other Comprehensive Income (Loss) on Level 3 Assets and Liabilities Held at September 30
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2023 | Balance, July 1 |
Included in
Net Income
|
Included in OCI | Purchases |
Sales
|
Settlements
|
Transfers into
Level 3 |
Transfers
out of
Level 3
|
Balance, September 30
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(In millions) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fixed maturity securities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Corporate bonds and other | $ |
|
|
$ |
(
|
$ |
|
|
$ |
(
|
|
|
$ |
|
|
$ |
(
|
||||||||||||||||||||||||||||||||||||||||||||||||
States, municipalities and political | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
subdivisions |
|
|
(
|
|
|
|
|
|
|
|
(
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
Asset-backed |
|
$ |
|
(
|
|
|
(
|
|
$ |
(
|
|
|
(
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
Fixed maturities available-for-sale | $ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
|||||||||||||||||||||||||||||||||||||||||||
Equity securities | $ |
|
$ |
(
|
|
|
$ |
(
|
|
|
|
$ |
|
$ |
(
|
|
23
|
Net Realized Investment Gains (Losses) and Net Change in Unrealized Investment Gains (Losses) |
Unrealized Gains (Losses) Recognized in Net Income (Loss) on Level 3 Assets and Liabilities Held at September 30
|
Unrealized Gains (Losses) Recognized in Other Comprehensive Income (Loss) on Level 3 Assets and Liabilities Held at September 30
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2022 | Balance, July 1 | Included in Net Income | Included in OCI | Purchases | Sales | Settlements |
Transfers into
Level 3 |
Transfers out of Level 3 |
Balance, September 30
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(In millions) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fixed maturity securities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Corporate bonds and other | $ |
|
$ |
|
$ |
(
|
$ |
|
|
$ |
(
|
|
|
$ |
|
|
$ |
(
|
|||||||||||||||||||||||||||||||||||||||||||||||
States, municipalities and political | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
subdivisions |
|
|
(
|
|
|
|
|
|
|
|
(
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
Asset-backed |
|
|
(
|
|
|
(
|
$ |
|
$ |
(
|
|
|
(
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
Fixed maturities available-for-sale | $ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
|||||||||||||||||||||||||||||||||||||||||||
Equity securities | $ |
|
$ |
(
|
|
|
|
|
|
$ |
(
|
$ |
|
$ |
(
|
|
Net Realized Investment Gains (Losses) and Net Change in Unrealized Investment Gains (Losses) |
Unrealized Gains (Losses) Recognized in Net Income (Loss) on Level 3 Assets and Liabilities Held at September 30
|
Unrealized Gains (Losses) Recognized in Other Comprehensive Income (Loss) on Level 3 Assets and Liabilities Held at September 30
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2023 | Balance, January 1 |
Included in
Net Income
|
Included in OCI | Purchases |
Sales
|
Settlements
|
Transfers into
Level 3 |
Transfers
out of
Level 3
|
Balance, September 30
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(In millions) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fixed maturity securities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Corporate bonds and other | $ |
|
|
$ |
(
|
$ |
|
|
$ |
(
|
$ |
|
|
$ |
|
|
$ |
(
|
|||||||||||||||||||||||||||||||||||||||||||||||
States, municipalities and political | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
subdivisions |
|
|
(
|
|
|
|
|
|
|
|
(
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
Asset-backed |
|
$ |
|
(
|
|
|
(
|
|
$ |
(
|
|
|
(
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
Fixed maturities available-for-sale | $ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
|||||||||||||||||||||||||||||||||||||||||||
Equity securities | $ |
|
$ |
(
|
|
|
$ |
(
|
|
|
|
$ |
|
$ |
(
|
|
24
|
Net Realized Investment Gains (Losses) and Net Change in Unrealized Investment Gains (Losses) |
Unrealized Gains (Losses) Recognized in Net Income (Loss) on Level 3 Assets and Liabilities Held at September 30
|
Unrealized Gains (Losses) Recognized in Other Comprehensive Income (Loss) on Level 3 Assets and Liabilities Held at September 30
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2022 | Balance, January 1 | Included in Net Income | Included in OCI | Purchases | Sales | Settlements |
Transfers into
Level 3 |
Transfers out of Level 3 |
Balance, September 30
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(In millions) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fixed maturity securities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Corporate bonds and other | $ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
|
$ |
|
|
$ |
(
|
|||||||||||||||||||||||||||||||||||||||||||||
States, municipalities and political | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
subdivisions |
|
|
(
|
|
|
|
|
|
|
|
(
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
Asset-backed |
|
|
(
|
|
(
|
(
|
|
$ |
(
|
|
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
Fixed maturities available-for-sale | $ |
|
$ |
|
$ |
(
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
|||||||||||||||||||||||||||||||||||||||||||
Equity securities | $ |
|
$ |
(
|
|
$ |
|
$ |
(
|
$ |
|
|
$ |
(
|
$ |
|
$ |
(
|
|
Major Category of Assets and Liabilities | Consolidated Condensed Statements of Operations Line Items | ||||
Fixed maturity securities available-for-sale | Investment gains (losses) | ||||
Fixed maturity securities trading | Net investment income | ||||
Equity securities | Investment gains (losses) and Net investment income | ||||
Other invested assets | Investment gains (losses) and Net investment income | ||||
Derivative financial instruments held in a trading portfolio | Net investment income | ||||
Derivative financial instruments, other | Investment gains (losses) and Operating revenues and other |
25
|
September 30, 2023 |
Estimated
Fair Value |
Valuation Techniques | Unobservable Inputs | Range (Weighted Average) | ||||||||||||||||||||||||||||
(In millions) | ||||||||||||||||||||||||||||||||
Fixed maturity securities | $ |
|
Discounted cash flow | Credit spread |
|
% | — |
|
% |
(
|
%) | |||||||||||||||||||||
December 31, 2022 | ||||||||||||||||||||||||||||||||
Fixed maturity securities | $ |
|
Discounted cash flow | Credit spread |
|
% | — |
|
% |
(
|
%) |
Carrying Amount | Estimated Fair Value | ||||||||||||||||||||||||||||
September 30, 2023 | Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||||||||
(In millions) | |||||||||||||||||||||||||||||
Assets: | |||||||||||||||||||||||||||||
Other invested assets, primarily mortgage loans | $ |
|
|
|
$ |
|
$ |
|
|||||||||||||||||||||
Liabilities: | |||||||||||||||||||||||||||||
Short term debt |
|
|
$ |
|
|
|
|||||||||||||||||||||||
Long term debt |
|
|
|
|
|
||||||||||||||||||||||||
December 31, 2022 | |||||||||||||||||||||||||||||
Assets: | |||||||||||||||||||||||||||||
Other invested assets, primarily mortgage loans | $ |
|
|
|
$ |
|
$ |
|
|||||||||||||||||||||
Liabilities: | |||||||||||||||||||||||||||||
Short term debt |
|
|
$ |
|
|
|
|||||||||||||||||||||||
Long term debt |
|
|
|
|
|
26
|
27
|
Nine Months Ended September 30
|
2023 |
2022
(a)
|
|||||||||||||||
(In millions) | |||||||||||||||||
Reserves, beginning of year: | |||||||||||||||||
Gross | $ |
|
$ |
|
|||||||||||||
Ceded |
|
|
|||||||||||||||
Net reserves, beginning of year |
|
|
|||||||||||||||
Net incurred claim and claim adjustment expenses: | |||||||||||||||||
Provision for insured events of current year |
|
|
|||||||||||||||
Increase (decrease) in provision for insured events of prior years |
|
(
|
|||||||||||||||
Amortization of discount |
|
|
|||||||||||||||
Total net incurred
(b)
|
|
|
|||||||||||||||
Net payments attributable to: | |||||||||||||||||
Current year events |
(
|
(
|
|||||||||||||||
Prior year events |
(
|
(
|
|||||||||||||||
Total net payments |
(
|
(
|
|||||||||||||||
Foreign currency translation adjustment and other |
(
|
(
|
|||||||||||||||
Net reserves, end of period |
|
|
|||||||||||||||
Ceded reserves, end of period |
|
|
|||||||||||||||
Gross reserves, end of period | $ |
|
$ |
|
(a) |
In conjunction with the adoption of ASU 2018-12, at January 1, 2023, long term care reserves for policyholders currently receiving benefits were reclassified from Claim and claim adjustment expenses into Future policy benefits and this change was applied retrospectively as of January 1, 2021. For additional information see
Note 1.
|
||||
(b) | Total net incurred above does not agree to Insurance claims and policyholders’ benefits as reflected on the Consolidated Condensed Statements of Operations due to amounts related to retroactive reinsurance deferred gain accounting and uncollectible reinsurance, which are not reflected in the table above. |
28
|
Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||
September 30, | September 30, | |||||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||||||||||||
(In millions) | ||||||||||||||||||||||||||
Medical professional liability |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||
Other professional liability and management liability | $ |
|
|
|
|
|||||||||||||||||||||
Surety |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Commercial auto |
|
|
|
|
||||||||||||||||||||||
General liability |
|
|
|
|
||||||||||||||||||||||
Workers’ compensation |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Warranty |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
Property and other |
|
|
|
(
|
||||||||||||||||||||||
Other insurance operations |
|
|
|
|
||||||||||||||||||||||
Total pretax (favorable) unfavorable development | $ |
|
$ |
(
|
$ |
|
$ |
(
|
29
|
30
|
31
|
2023 | 2022 | ||||||||||
(In millions) | |||||||||||
Present value of future net premiums | |||||||||||
Balance, January 1 | $ |
|
$ |
|
|||||||
Effect of changes in discount rate |
(
|
(
|
|||||||||
Balance, January 1, at original locked in discount rate |
|
|
|||||||||
Effect of changes in cash flow assumptions (a) |
|
|
|||||||||
Effect of actual variances from expected experience (a) |
(
|
(
|
|||||||||
Adjusted balance, January 1 |
|
|
|||||||||
Interest accrual |
|
|
|||||||||
Net premiums: earned during period |
(
|
(
|
|||||||||
Balance, end of period at original locked in discount rate |
|
|
|||||||||
Effect of changes in discount rate |
(
|
|
|||||||||
Balance, September 30
|
$ |
|
$ |
|
|||||||
Present value of future benefits & expenses | |||||||||||
Balance, January 1 | $ |
|
$ |
|
|||||||
Effect of changes in discount rate |
(
|
(
|
|||||||||
Balance, January 1, at original locked in discount rate |
|
|
|||||||||
Effect of changes in cash flow assumptions (a) |
|
|
|||||||||
Effect of actual variances from expected experience (a) |
(
|
(
|
|||||||||
Adjusted balance, January 1 |
|
|
|||||||||
Interest accrual |
|
|
|||||||||
Benefit & expense payments |
(
|
(
|
|||||||||
Balance, end of period at original locked in discount rate |
|
|
|||||||||
Effect of changes in discount rate |
(
|
(
|
|||||||||
Balance, September 30
|
$ |
|
$ |
|
|||||||
Net LFPB, September 30 | $ |
|
$ |
|
(a) |
As of
September 30, 2023
and
2022
, the re-measurement loss of $(
|
32
|
Three Months Ended | Nine Months Ended | |||||||||||||||||||
September 30, | September 30, | |||||||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||||||
(In millions) | ||||||||||||||||||||
Earned premiums | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||
Interest expense |
|
|
|
|
September 30, | |||||||||||
2023 | 2022 | ||||||||||
(In millions) | |||||||||||
Expected future benefit and expense payments | $ |
|
$ |
|
|||||||
Expected future gross premiums |
|
|
September 30, | December 31, | ||||||||||||||||
2023 | 2022 | 2022 | |||||||||||||||
Original locked in discount rate |
|
% |
|
% |
|
% | |||||||||||
Upper-medium grade fixed income instrument discount rate |
|
|
|
33
|
Net Unrealized Gains (Losses) on Investments with an Allowance for Credit Losses | Net Unrealized Gains (Losses) on Other Investments |
Cumulative
impact of changes in discount rates used to measure long duration contracts |
Unrealized Gains (Losses) on Cash Flow Hedges | Pension and Postretirement Benefits | Foreign Currency Translation | Total Accumulated Other Comprehensive Income (Loss) | |||||||||||||||||||||||||||||||||||
(In millions) | |||||||||||||||||||||||||||||||||||||||||
Balance, July 1, 2022, as reported
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||||||||||||||
Cumulative effect adjustments from changes in accounting standards (Note 1), after tax of $
|
|
(
|
(
|
||||||||||||||||||||||||||||||||||||||
Balance, July 1, 2022, as adjusted
|
(
|
(
|
(
|
|
(
|
(
|
(
|
||||||||||||||||||||||||||||||||||
Other comprehensive income (loss) before reclassifications, after tax of $
|
|
(
|
|
|
|
(
|
(
|
||||||||||||||||||||||||||||||||||
Reclassification of (gains) losses from accumulated other comprehensive income, after tax of $
|
(
|
|
(
|
|
|
|
|||||||||||||||||||||||||||||||||||
Other comprehensive income (loss) |
(
|
(
|
|
|
|
(
|
(
|
||||||||||||||||||||||||||||||||||
Amounts attributable to noncontrolling interests |
(
|
|
(
|
|
(
|
|
|
||||||||||||||||||||||||||||||||||
Balance, September 30, 2022
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||||||||||||||
Balance, July 1, 2023
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||||||||||||||
Other comprehensive income (loss) before reclassifications, after tax of $
|
(
|
(
|
|
(
|
|
(
|
(
|
||||||||||||||||||||||||||||||||||
Reclassification of losses from accumulated other comprehensive loss, after tax of $(
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||
Other comprehensive income (loss) |
(
|
(
|
|
(
|
|
(
|
(
|
||||||||||||||||||||||||||||||||||
Amounts attributable to noncontrolling interests |
|
|
(
|
|
(
|
|
|
||||||||||||||||||||||||||||||||||
Purchase of CNA shares |
|
(
|
(
|
|
(
|
(
|
(
|
||||||||||||||||||||||||||||||||||
Balance, September 30, 2023
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
(
|
34
|
Net Unrealized Gains (Losses) on Investments with an Allowance for Credit Losses | Net Unrealized Gains (Losses) on Other Investments |
Cumulative
impact of changes in discount rates used to measure long duration contracts |
Unrealized Gains (Losses) on Cash Flow Hedges | Pension and Postretirement Benefits | Foreign Currency Translation | Total Accumulated Other Comprehensive Income (Loss) | |||||||||||||||||||||||||||||||||||
(In millions) | |||||||||||||||||||||||||||||||||||||||||
Balance, January 1, 2022, as reported
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||
Cumulative effect adjustments from changes in accounting standards (Note 1), after tax of $
|
|
(
|
(
|
||||||||||||||||||||||||||||||||||||||
Balance, January 1, 2022, as adjusted
|
(
|
|
(
|
(
|
(
|
(
|
(
|
||||||||||||||||||||||||||||||||||
Other comprehensive income (loss) before reclassifications, after tax of $
|
(
|
(
|
|
|
|
(
|
(
|
||||||||||||||||||||||||||||||||||
Reclassification of (gains) losses from accumulated other comprehensive loss, after tax of $
|
(
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
Other comprehensive income (loss) |
(
|
(
|
|
|
|
(
|
(
|
||||||||||||||||||||||||||||||||||
Amounts attributable to noncontrolling interests |
|
|
(
|
|
(
|
|
|
||||||||||||||||||||||||||||||||||
Balance, September 30, 2022
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||||||||||||||
Balance, January 1, 2023, as reported
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||||||||||||||
Cumulative effect adjustments from changes in accounting standards (Note 1), after tax of $
|
(
|
(
|
|||||||||||||||||||||||||||||||||||||||
Balance, January 1, 2023, as adjusted
|
(
|
(
|
(
|
|
(
|
(
|
(
|
||||||||||||||||||||||||||||||||||
Other comprehensive income (loss) before reclassifications, after tax of $
|
(
|
(
|
|
|
|
(
|
(
|
||||||||||||||||||||||||||||||||||
Reclassification of losses from accumulated other comprehensive loss, after tax of $(
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
Other comprehensive income (loss) |
(
|
(
|
|
|
|
(
|
(
|
||||||||||||||||||||||||||||||||||
Amounts attributable to noncontrolling interests |
|
|
(
|
|
(
|
|
|
||||||||||||||||||||||||||||||||||
Purchase of CNA shares |
|
(
|
(
|
|
(
|
(
|
(
|
||||||||||||||||||||||||||||||||||
Balance, September 30, 2023
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
(
|
Major Category of AOCI | Affected Line Item | ||||
Net unrealized gains (losses) on investments with an allowance for credit losses and Net unrealized gains (losses) on other investments | Investment gains (losses) | ||||
Unrealized gains (losses) on cash flow hedges | Operating revenues and other, Interest expense and Operating expenses and other | ||||
Pension and postretirement benefits | Operating expenses and other |
35
|
Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||
September 30, | September 30, | |||||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||||||||||||
(In millions) | ||||||||||||||||||||||||||
Non-insurance warranty – CNA Financial | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
Transportation and storage of natural gas and NGLs and other services – Boardwalk Pipelines | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
Lodging and related services – Loews Hotels & Co |
|
|
|
|
||||||||||||||||||||||
Total revenues from contracts with customers |
|
|
|
|
||||||||||||||||||||||
Other revenues |
|
|
|
|
||||||||||||||||||||||
Operating revenues and other | $ |
|
$ |
|
$ |
|
$ |
|
36
|
Pension Benefits | |||||||||||||||||||||||||||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||||||||||||
September 30, | September 30, | ||||||||||||||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||||||||||||||
(In millions) | |||||||||||||||||||||||||||||||||||
Service cost | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||
Interest cost |
|
|
|
|
|||||||||||||||||||||||||||||||
Expected return on plan assets |
(
|
(
|
(
|
(
|
|||||||||||||||||||||||||||||||
Amortization of unrecognized net loss |
|
|
|
|
|||||||||||||||||||||||||||||||
Settlements |
|
|
|
|
|||||||||||||||||||||||||||||||
Regulatory asset decrease |
|
(
|
|
|
|||||||||||||||||||||||||||||||
Net periodic (benefit) cost | $ |
|
$ |
(
|
$ |
|
$ |
(
|
Other Postretirement Benefits | |||||||||||||||||||||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||||||
September 30, | September 30, | ||||||||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||||||||
(In millions) | |||||||||||||||||||||||||||||
Interest cost |
|
|
$ |
|
$ |
|
|||||||||||||||||||||||
Expected return on plan assets | $ |
(
|
|
(
|
(
|
||||||||||||||||||||||||
Amortization of unrecognized net loss |
|
|
|
|
|||||||||||||||||||||||||
Net periodic benefit | $ |
|
$ |
|
$ |
|
$ |
|
37
|
38
|
Three Months Ended September 30, 2023 |
CNA Financial
|
Boardwalk Pipelines
|
Loews
Hotels & Co
|
Corporate |
Total
|
||||||||||||||||||||||||||||||
(In millions) | |||||||||||||||||||||||||||||||||||
Revenues: | |||||||||||||||||||||||||||||||||||
Insurance premiums | $ |
|
|
|
|
$ |
|
||||||||||||||||||||||||||||
Net investment income |
|
$ |
|
$ |
|
$ |
|
|
|||||||||||||||||||||||||||
Investment losses |
(
|
|
|
|
(
|
||||||||||||||||||||||||||||||
Non-insurance warranty revenue |
|
|
|
|
|
||||||||||||||||||||||||||||||
Operating revenues and other |
|
|
|
|
|
||||||||||||||||||||||||||||||
Total |
|
|
|
|
|
||||||||||||||||||||||||||||||
Expenses: | |||||||||||||||||||||||||||||||||||
Insurance claims and policyholders’ benefits |
|
|
|
|
|
||||||||||||||||||||||||||||||
Amortization of deferred acquisition costs |
|
|
|
|
|
||||||||||||||||||||||||||||||
Non-insurance warranty expense |
|
|
|
|
|
||||||||||||||||||||||||||||||
Operating expenses and other |
|
|
|
|
|
||||||||||||||||||||||||||||||
Equity method (income) loss |
|
|
(
|
|
(
|
||||||||||||||||||||||||||||||
Interest |
|
|
|
|
|
||||||||||||||||||||||||||||||
Total |
|
|
|
|
|
||||||||||||||||||||||||||||||
Income (loss) before income tax |
|
|
|
(
|
|
||||||||||||||||||||||||||||||
Income tax (expense) benefit |
(
|
(
|
(
|
|
(
|
||||||||||||||||||||||||||||||
Net income (loss) |
|
|
|
(
|
|
||||||||||||||||||||||||||||||
Amounts attributable to noncontrolling interests |
(
|
|
|
|
(
|
||||||||||||||||||||||||||||||
Net income (loss) attributable to Loews Corporation | $ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
39
|
Three Months Ended September 30, 2022 | CNA Financial (a) | Boardwalk Pipelines |
Loews
Hotels & Co |
Corporate | Total (a) | ||||||||||||||||||||||||||||||
(In millions) | |||||||||||||||||||||||||||||||||||
Revenues: | |||||||||||||||||||||||||||||||||||
Insurance premiums | $ |
|
|
|
|
$ |
|
||||||||||||||||||||||||||||
Net investment income (loss) |
|
$ |
|
|
$ |
(
|
|
||||||||||||||||||||||||||||
Investment losses |
(
|
|
|
|
(
|
||||||||||||||||||||||||||||||
Non-insurance warranty revenue |
|
|
|
|
|
||||||||||||||||||||||||||||||
Operating revenues and other |
|
|
$ |
|
|
|
|||||||||||||||||||||||||||||
Total |
|
|
|
(
|
|
||||||||||||||||||||||||||||||
Expenses: | |||||||||||||||||||||||||||||||||||
Insurance claims and policyholders’ benefits |
|
|
|
|
|
||||||||||||||||||||||||||||||
Amortization of deferred acquisition costs |
|
|
|
|
|
||||||||||||||||||||||||||||||
Non-insurance warranty expense |
|
|
|
|
|
||||||||||||||||||||||||||||||
Operating expenses and other |
|
|
|
|
|
||||||||||||||||||||||||||||||
Equity method (income) loss |
|
|
(
|
|
(
|
||||||||||||||||||||||||||||||
Interest |
|
|
(
|
|
|
||||||||||||||||||||||||||||||
Total |
|
|
|
|
|
||||||||||||||||||||||||||||||
Income (loss) before income tax |
(
|
|
|
(
|
(
|
||||||||||||||||||||||||||||||
Income tax (expense) benefit |
|
(
|
(
|
|
(
|
||||||||||||||||||||||||||||||
Net income (loss) |
(
|
|
|
(
|
(
|
||||||||||||||||||||||||||||||
Amounts attributable to noncontrolling interests |
|
|
|
|
|
||||||||||||||||||||||||||||||
Net income (loss) attributable to Loews Corporation | $ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
(a) | As of January 1, 2023, ASU 2018-12 was adopted using the modified retrospective method applied as of the transition date of January 1, 2021. Prior period amounts in the financial statements have been adjusted to reflect application of the new standard. For additional information see Note 1. |
40
|
Nine Months Ended September 30, 2023 | CNA Financial | Boardwalk Pipelines | Loews Hotels & Co | Corporate | Total | ||||||||||||||||||||||||||||||
(In millions) | |||||||||||||||||||||||||||||||||||
Revenues: | |||||||||||||||||||||||||||||||||||
Insurance premiums | $ |
|
|
|
|
$ |
|
||||||||||||||||||||||||||||
Net investment income |
|
$ |
|
$ |
|
$ |
|
|
|||||||||||||||||||||||||||
Investment gains (losses) |
(
|
|
|
|
(
|
||||||||||||||||||||||||||||||
Non-insurance warranty revenue |
|
|
|
|
|
||||||||||||||||||||||||||||||
Operating revenues and other |
|
|
|
|
|
||||||||||||||||||||||||||||||
Total |
|
|
|
|
|
||||||||||||||||||||||||||||||
Expenses: | |||||||||||||||||||||||||||||||||||
Insurance claims and policyholders’ benefits |
|
|
|
|
|
||||||||||||||||||||||||||||||
Amortization of deferred acquisition costs |
|
|
|
|
|
||||||||||||||||||||||||||||||
Non-insurance warranty expense |
|
|
|
|
|
||||||||||||||||||||||||||||||
Operating expenses and other |
|
|
|
|
|
||||||||||||||||||||||||||||||
Equity method (income) loss |
|
|
(
|
|
(
|
||||||||||||||||||||||||||||||
Interest |
|
|
|
|
|
||||||||||||||||||||||||||||||
Total |
|
|
|
|
|
||||||||||||||||||||||||||||||
Income (loss) before income tax |
|
|
|
(
|
|
||||||||||||||||||||||||||||||
Income tax (expense) benefit |
(
|
(
|
(
|
|
(
|
||||||||||||||||||||||||||||||
Net income (loss) |
|
|
|
(
|
|
||||||||||||||||||||||||||||||
Amounts attributable to noncontrolling interests |
(
|
|
|
|
(
|
||||||||||||||||||||||||||||||
Net income (loss) attributable to Loews Corporation | $ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
41
|
Nine Months Ended September 30, 2022 | CNA Financial (a) | Boardwalk Pipelines | Loews Hotels & Co | Corporate | Total (a) | ||||||||||||||||||||||||||||||
(In millions) | |||||||||||||||||||||||||||||||||||
Revenues: | |||||||||||||||||||||||||||||||||||
Insurance premiums | $ |
|
|
|
|
$ |
|
||||||||||||||||||||||||||||
Net investment income (loss) |
|
$ |
|
$ |
(
|
$ |
(
|
|
|||||||||||||||||||||||||||
Investment losses |
(
|
|
|
|
(
|
||||||||||||||||||||||||||||||
Non-insurance warranty revenue |
|
|
|
|
|
||||||||||||||||||||||||||||||
Operating revenues and other |
|
|
|
|
|
||||||||||||||||||||||||||||||
Total |
|
|
|
(
|
|
||||||||||||||||||||||||||||||
Expenses: | |||||||||||||||||||||||||||||||||||
Insurance claims and policyholders’ benefits |
|
|
|
|
|
||||||||||||||||||||||||||||||
Amortization of deferred acquisition costs |
|
|
|
|
|
||||||||||||||||||||||||||||||
Non-insurance warranty expense |
|
|
|
|
|
||||||||||||||||||||||||||||||
Operating expenses and other |
|
|
|
|
|
||||||||||||||||||||||||||||||
Equity method (income) loss |
|
|
(
|
|
(
|
||||||||||||||||||||||||||||||
Interest |
|
|
|
|
|
||||||||||||||||||||||||||||||
Total |
|
|
|
|
|
||||||||||||||||||||||||||||||
Income (loss) before income tax |
|
|
|
(
|
|
||||||||||||||||||||||||||||||
Income tax (expense) benefit |
(
|
(
|
(
|
|
(
|
||||||||||||||||||||||||||||||
Net income (loss) |
|
|
|
(
|
|
||||||||||||||||||||||||||||||
Amounts attributable to noncontrolling interests |
(
|
|
|
|
(
|
||||||||||||||||||||||||||||||
Net income (loss) attributable to Loews Corporation | $ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
(a) | As of January 1, 2023, ASU 2018-12 was adopted using the modified retrospective method applied as of the transition date of January 1, 2021. Prior period amounts in the financial statements have been adjusted to reflect application of the new standard. For additional information see Note 1. |
42
|
Page
No.
|
|||||
43
|
Three Months Ended | Nine Months Ended | |||||||||||||||||||
September 30, | September 30, | |||||||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||||||
(In millions, except per share data) | ||||||||||||||||||||
CNA Financial (a) | $ | 235 | $ | (37) | $ | 758 | $ | 398 | ||||||||||||
Boardwalk Pipelines | 49 | 34 | 191 | 164 | ||||||||||||||||
Loews Hotels & Co | 17 | 25 | 115 | 84 | ||||||||||||||||
Corporate | (48) | (44) | (76) | (179) | ||||||||||||||||
Net income (loss) attributable to Loews Corporation | $ | 253 | $ | (22) | $ | 988 | $ | 467 | ||||||||||||
Basic net income (loss) per share | $ | 1.12 | $ | (0.09) | $ | 4.32 | $ | 1.91 | ||||||||||||
Diluted net income (loss) per share (a) | $ | 1.12 | $ | (0.09) | $ | 4.31 | $ | 1.90 |
(a) |
As of January 1, 2023, Accounting Standards Update (“ASU”) 2018-12, “
Financial Services – Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts,” (“ASU 2018-12”)
was adopted using the modified retrospective method applied as of the transition date of January 1, 2021. Prior period amounts presented in the financial statements have been adjusted to reflect application of the new guidance. For additional information see
Notes 1 and
6
of the Notes to Consolidated Condensed Financial Statements included under Item 1 of this Report.
|
44
|
Three Months Ended | Nine Months Ended | |||||||||||||||||||
September 30, | September 30, | |||||||||||||||||||
2023 | 2022 (a) | 2023 | 2022 (a) | |||||||||||||||||
(In millions) | ||||||||||||||||||||
Revenues: | ||||||||||||||||||||
Insurance premiums | $ | 2,406 | $ | 2,221 | $ | 7,001 | $ | 6,435 | ||||||||||||
Net investment income | 553 | 422 | 1,653 | 1,302 | ||||||||||||||||
Investment losses | (38) | (96) | (105) | (166) | ||||||||||||||||
Non-insurance warranty revenue | 407 | 399 | 1,221 | 1,173 | ||||||||||||||||
Other revenues | 8 | 11 | 22 | 24 | ||||||||||||||||
Total | 3,336 | 2,957 | 9,792 | 8,768 | ||||||||||||||||
Expenses: | ||||||||||||||||||||
Insurance claims and policyholders’ benefits | 1,826 | 1,880 | 5,258 | 4,959 | ||||||||||||||||
Amortization of deferred acquisition costs | 426 | 383 | 1,208 | 1,101 | ||||||||||||||||
Non-insurance warranty expense | 386 | 371 | 1,154 | 1,092 | ||||||||||||||||
Other operating expenses | 338 | 346 | 1,021 | 1,001 | ||||||||||||||||
Interest | 34 | 28 | 93 | 84 | ||||||||||||||||
Total | 3,010 | 3,008 | 8,734 | 8,237 | ||||||||||||||||
Income (loss) before income tax | 326 | (51) | 1,058 | 531 | ||||||||||||||||
Income tax (expense) benefit | (68) | 9 | (220) | (88) | ||||||||||||||||
Net income (loss) | 258 | (42) | 838 | 443 | ||||||||||||||||
Amounts attributable to noncontrolling interests | (23) | 5 | (80) | (45) | ||||||||||||||||
Net income (loss) attributable to Loews Corporation | $ | 235 | $ | (37) | $ | 758 | $ | 398 |
(a) |
As of January 1, 2023, ASU 2018-12 was adopted using the modified retrospective method applied as of the transition date of January 1, 2021. Prior period amounts presented in the financial statements have been adjusted to reflect application of the new guidance. For additional information see
Notes 1 and
6
of the Notes to Consolidated Condensed Financial Statements included under Item 1 of this Report.
|
45
|
46
|
Three Months Ended September 30, 2023 |
Specialty
|
Commercial
|
International
|
Total
|
|||||||||||||||||||
(In millions, except %) | |||||||||||||||||||||||
Gross written premiums | $ | 1,775 | $ | 1,343 | $ | 306 | $ | 3,424 | |||||||||||||||
Gross written premiums excluding third-party captives | 949 | 1,340 | 306 | 2,595 | |||||||||||||||||||
Net written premiums | 825 | 1,071 | 282 | 2,178 | |||||||||||||||||||
Net earned premiums | 829 | 1,170 | 296 | 2,295 | |||||||||||||||||||
Underwriting gain | 83 | 13 | 35 | 131 | |||||||||||||||||||
Net investment income | 136 | 156 | 26 | 318 | |||||||||||||||||||
Core income | 178 | 133 | 40 | 351 | |||||||||||||||||||
Other performance metrics: | |||||||||||||||||||||||
Loss ratio excluding catastrophes and development | 58.6 | % | 61.5 | % | 57.9 | % | 60.0 | % | |||||||||||||||
Effect of catastrophe impacts | 7.4 | 2.3 | 4.1 | ||||||||||||||||||||
Effect of development-related items | (0.6) | (0.2) | |||||||||||||||||||||
Loss ratio | 58.0 | % | 68.9 | % | 60.2 | % | 63.9 | % | |||||||||||||||
Expense ratio | 31.8 | 29.5 | 28.1 | 30.1 | |||||||||||||||||||
Dividend ratio | 0.3 | 0.5 | 0.3 | ||||||||||||||||||||
Combined ratio | 90.1 | % | 98.9 | % | 88.3 | % | 94.3 | % | |||||||||||||||
Combined ratio excluding catastrophes and development | 90.7 | % | 91.5 | % | 86.0 | % | 90.4 | % | |||||||||||||||
Rate | 1 | % | 8 | % | 2 | % | 5 | % | |||||||||||||||
Renewal premium change | 2 | 9 | 7 | 6 | |||||||||||||||||||
Retention | 87 | 83 | 84 | 84 | |||||||||||||||||||
New business | $ | 121 | $ | 292 | $ | 62 | $ | 475 |
Three Months Ended September 30, 2022 | |||||||||||||||||||||||
Gross written premiums | $ | 1,890 | $ | 1,187 | $ | 288 | $ | 3,365 | |||||||||||||||
Gross written premiums excluding third-party captives | 958 | 1,184 | 288 | 2,430 | |||||||||||||||||||
Net written premiums | 840 | 962 | 258 | 2,060 | |||||||||||||||||||
Net earned premiums | 810 | 1,023 | 270 | 2,103 | |||||||||||||||||||
Underwriting gain (loss) | 92 | (23) | 15 | 84 | |||||||||||||||||||
Net investment income | 102 | 112 | 16 | 230 | |||||||||||||||||||
Core income | 161 | 80 | 19 | 260 | |||||||||||||||||||
Other performance metrics: | |||||||||||||||||||||||
Loss ratio excluding catastrophes and development | 58.4 | % | 61.5 | % | 58.6 | % | 59.9 | % | |||||||||||||||
Effect of catastrophe impacts | 0.2 | 10.0 | 4.1 | 5.5 | |||||||||||||||||||
Effect of development-related items | (1.9) | (0.8) | |||||||||||||||||||||
Loss ratio | 56.7 | % | 71.5 | % | 62.7 | % | 64.6 | % | |||||||||||||||
Expense ratio | 31.7 | 29.9 | 31.7 | 30.8 | |||||||||||||||||||
Dividend ratio | 0.3 | 0.5 | 0.4 | ||||||||||||||||||||
Combined ratio | 88.7 | % | 101.9 | % | 94.4 | % | 95.8 | % | |||||||||||||||
Combined ratio excluding catastrophes and development | 90.4 | % | 91.9 | % | 90.3 | % | 91.1 | % | |||||||||||||||
Rate | 5 | % | 4 | % | 6 | % | 5 | % | |||||||||||||||
Renewal premium change | 6 | 7 | 15 | 8 | |||||||||||||||||||
Retention | 88 | 86 | 83 | 86 | |||||||||||||||||||
New business | $ | 130 | $ | 246 | $ | 79 | $ | 455 |
47
|
Nine Months Ended September 30, 2023 |
Specialty
|
Commercial
|
International
|
Total
|
|||||||||||||||||||
(In millions, except %) | |||||||||||||||||||||||
Gross written premiums | $ | 5,324 | $ | 4,504 | $ | 1,125 | $ | 10,953 | |||||||||||||||
Gross written premiums excluding third-party captives | 2,796 | 4,384 | 1,125 | 8,305 | |||||||||||||||||||
Net written premiums | 2,438 | 3,588 | 912 | 6,938 | |||||||||||||||||||
Net earned premiums | 2,438 | 3,336 | 888 | 6,662 | |||||||||||||||||||
Underwriting gain | 237 | 96 | 66 | 399 | |||||||||||||||||||
Net investment income | 407 | 470 | 74 | 951 | |||||||||||||||||||
Core income | 526 | 443 | 102 | 1,071 | |||||||||||||||||||
Other performance metrics: | |||||||||||||||||||||||
Loss ratio excluding catastrophes and development | 58.5 | % | 61.5 | % | 57.8 | % | 59.9 | % | |||||||||||||||
Effect of catastrophe impacts | 5.7 | 2.7 | 3.2 | ||||||||||||||||||||
Effect of development-related items | (0.3) | (0.2) | 1.7 | ||||||||||||||||||||
Loss ratio | 58.2 | % | 67.0 | % | 62.2 | % | 63.1 | % | |||||||||||||||
Expense ratio | 31.9 | 29.6 | 30.3 | 30.6 | |||||||||||||||||||
Dividend ratio | 0.2 | 0.5 | 0.3 | ||||||||||||||||||||
Combined ratio | 90.3 | % | 97.1 | % | 92.5 | % | 94.0 | % | |||||||||||||||
Combined ratio excluding catastrophes and development | 90.6 | % | 91.6 | % | 88.1 | % | 90.8 | % | |||||||||||||||
Rate | 1 | % | 8 | % | 4 | % | 5 | % | |||||||||||||||
Renewal premium change | 2 | 10 | 7 | 7 | |||||||||||||||||||
Retention | 88 | 85 | 83 | 85 | |||||||||||||||||||
New business | $ | 349 | $ | 945 | $ | 239 | $ | 1,533 |
Nine Months Ended September 30, 2022 | |||||||||||||||||||||||
Gross written premiums | $ | 5,640 | $ | 3,824 | $ | 1,033 | $ | 10,497 | |||||||||||||||
Gross written premiums excluding third-party captives | 2,816 | 3,711 | 1,033 | 7,560 | |||||||||||||||||||
Net written premiums | 2,443 | 3,097 | 839 | 6,379 | |||||||||||||||||||
Net earned premiums | 2,376 | 2,901 | 803 | 6,080 | |||||||||||||||||||
Underwriting gain | 273 | 94 | 58 | 425 | |||||||||||||||||||
Net investment income | 305 | 343 | 44 | 692 | |||||||||||||||||||
Core income | 485 | 350 | 63 | 898 | |||||||||||||||||||
Other performance metrics: | |||||||||||||||||||||||
Loss ratio excluding catastrophes and development | 58.6 | % | 61.5 | % | 58.6 | % | 60.0 | % | |||||||||||||||
Effect of catastrophe impacts | 0.1 | 5.0 | 2.7 | 2.8 | |||||||||||||||||||
Effect of development-related items | (1.4) | (0.5) | (0.6) | (0.9) | |||||||||||||||||||
Loss ratio | 57.3 | % | 66.0 | % | 60.7 | % | 61.9 | % | |||||||||||||||
Expense ratio | 31.0 | 30.1 | 32.1 | 30.8 | |||||||||||||||||||
Dividend ratio | 0.2 | 0.5 | 0.3 | ||||||||||||||||||||
Combined ratio | 88.5 | % | 96.6 | % | 92.8 | % | 93.0 | % | |||||||||||||||
Combined ratio excluding catastrophes and development | 89.8 | % | 92.1 | % | 90.7 | % | 91.1 | % | |||||||||||||||
Rate | 7 | % | 5 | % | 7 | % | 6 | % | |||||||||||||||
Renewal premium change | 8 | 8 | 11 | 8 | |||||||||||||||||||
Retention | 86 | 86 | 79 | 85 | |||||||||||||||||||
New business | $ | 407 | $ | 754 | $ | 245 | $ | 1,406 |
48
|
49
|
50
|
Three Months Ended | Nine Months Ended | |||||||||||||||||||
September 30, | September 30, | |||||||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||||||
(In millions) | ||||||||||||||||||||
Net earned premiums | $ | 112 | $ | 118 | $ | 340 | $ | 356 | ||||||||||||
Net investment income | 235 | 192 | 702 | 610 | ||||||||||||||||
Core loss
(a)
|
(62) | (217) | (149) | (327) |
(a) |
As of January 1, 2023, ASU 2018-12 was adopted using the modified retrospective method applied as of the transition date of January 1, 2021. Prior period amounts presented in the financial statements have been adjusted to reflect application of the new guidance. Core loss for Other Insurance Operations for the three and nine months ended September 30, 2022 was adjusted by $(170) million and $(203) million as a result of adopting the standard. For additional information see Notes 1 and 6 of the Notes to Consolidated Condensed Financial Statements included under Item 1 of this Report.
|
51
|
September 30, 2023
|
Estimated Reduction to Pretax Income | ||||
(In millions) | |||||
Hypothetical revisions | |||||
Morbidity: | |||||
2.5% increase in morbidity | $ | 275 | |||
5% increase in morbidity | 600 | ||||
Persistency: | |||||
5% decrease in active life mortality and lapse | $ | 150 | |||
10% decrease in active life mortality and lapse | 300 | ||||
Premium rate actions: | |||||
25% decrease in anticipated future premium rate increases | $ | 25 | |||
50% decrease in anticipated future premium rate increases | 50 | ||||
September 30, 2023 | Claim and claim adjustment expenses | Future policy benefits | Total | ||||||||||||||
(In millions) | |||||||||||||||||
Long term care | $ | 12,654 | $ | 12,654 | |||||||||||||
Structured settlement annuities and other | $ | 552 | 552 | ||||||||||||||
Total | 552 | 12,654 | 13,206 | ||||||||||||||
Ceded reserves | 97 | 97 | |||||||||||||||
Total gross reserves | $ | 649 | $ | 12,654 | $ | 13,303 |
52
|
December 31, 2022 | Claim and claim adjustment expenses | Future policy benefits | Total | ||||||||||||||
(In millions) | |||||||||||||||||
Long term care (a)(b) | $ | 13,480 | $ | 13,480 | |||||||||||||
Structured settlement annuities and other | $ | 594 | 594 | ||||||||||||||
Total | 594 | 13,480 | 14,074 | ||||||||||||||
Ceded reserves | 101 | 101 | |||||||||||||||
Total gross reserves | $ | 695 | $ | 13,480 | $ | 14,175 |
(a) |
As of January 1, 2023, ASU 2018-12 was adopted using the modified retrospective method applied as of the transition date of January 1, 2021. Prior period amounts presented in the financial statements have been adjusted to reflect application of the new guidance. For additional information see
Notes 1 and
6
of the Notes to Consolidated Condensed Financial Statements included under Item 1 of this Report.
|
||||
(b) |
In conjunction with the adoption of ASU 2018-12, at January 1, 2023 the long term care reserves for policyholders currently receiving benefits were reclassified from Claim and claim adjustment expenses to Future policy benefits. This change was applied retrospectively as of January 1, 2021.
|
53
|
Three Months Ended | Nine Months Ended | |||||||||||||||||||
September 30, | September 30, | |||||||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||||||
(In millions) | ||||||||||||||||||||
Net income (loss) attributable to Loews Corporation (a) | $ | 235 | $ | (37) | $ | 758 | $ | 398 | ||||||||||||
Investment losses | 31 | 84 | 84 | 127 | ||||||||||||||||
Consolidation adjustments including
noncontrolling interests (a)
|
23 | (4) | 80 | 46 | ||||||||||||||||
Total core income | $ | 289 | $ | 43 | $ | 922 | $ | 571 | ||||||||||||
Core income (loss): | ||||||||||||||||||||
Property & Casualty Operations | $ | 351 | $ | 260 | 1,071 | $ | 898 | |||||||||||||
Other Insurance Operations (a) | (62) | (217) | (149) | (327) | ||||||||||||||||
Total core income | $ | 289 | $ | 43 | $ | 922 | $ | 571 |
(a) |
As of January 1, 2023, ASU 2018-12 was adopted using the modified retrospective method applied as of the transition date of January 1, 2021. Prior period amounts presented in the financial statements have been adjusted to reflect application of the new guidance. Core loss for Other Insurance Operations for the three and nine months ended September 30, 2022 was adjusted by $(170) million and $(203) million as a result of adopting the standard. For additional information see Notes 1 and 6 of the Notes to Consolidated Condensed Financial Statements included under Item 1 of this Report.
|
54
|
Three Months Ended | Nine Months Ended | |||||||||||||||||||
September 30, | September 30, | |||||||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||||||
(In millions) | ||||||||||||||||||||
Revenues: | ||||||||||||||||||||
Operating revenues and other | $ | 357 | $ | 339 | $ | 1,114 | $ | 1,045 | ||||||||||||
Interest income | 6 | 11 | ||||||||||||||||||
Total | 363 | 339 | 1,125 | 1,045 | ||||||||||||||||
Expenses: | ||||||||||||||||||||
Operating and other: | ||||||||||||||||||||
Operating costs and expenses | 155 | 147 | 445 | 401 | ||||||||||||||||
Depreciation and amortization | 103 | 103 | 306 | 297 | ||||||||||||||||
Interest | 39 | 42 | 117 | 126 | ||||||||||||||||
Total | 297 | 292 | 868 | 824 | ||||||||||||||||
Income before income tax | 66 | 47 | 257 | 221 | ||||||||||||||||
Income tax expense | (17) | (13) | (66) | (57) | ||||||||||||||||
Net income attributable to Loews Corporation | $ | 49 | $ | 34 | $ | 191 | $ | 164 | ||||||||||||
EBITDA | $ | 202 | $ | 192 | $ | 669 | $ | 644 |
55
|
Three Months Ended
|
Nine Months Ended
|
|||||||||||||||||||
September 30,
|
September 30,
|
|||||||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||||||
(In millions)
|
||||||||||||||||||||
Net income attributable to Loews Corporation
|
$ | 49 | $ | 34 | $ | 191 | $ | 164 | ||||||||||||
Interest, net
|
33 | 42 | 106 | 126 | ||||||||||||||||
Income tax expense
|
17 | 13 | 66 | 57 | ||||||||||||||||
Depreciation and amortization
|
103 | 103 | 306 | 297 | ||||||||||||||||
EBITDA
|
$ | 202 | $ | 192 | $ | 669 | $ | 644 |
56
|
Three Months Ended | Nine Months Ended | |||||||||||||||||||
September 30, | September 30, | |||||||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||||||
(In millions) | ||||||||||||||||||||
Revenues: | ||||||||||||||||||||
Operating revenue | $ | 160 | $ | 149 | $ | 497 | $ | 440 | ||||||||||||
Gain on acquisition of a joint venture | 46 | |||||||||||||||||||
Revenues related to reimbursable expenses | 36 | 31 | 99 | 92 | ||||||||||||||||
Total | 196 | 180 | 642 | 532 | ||||||||||||||||
Expenses: | ||||||||||||||||||||
Operating and other: | ||||||||||||||||||||
Operating | 141 | 128 | 413 | 359 | ||||||||||||||||
Asset impairments | 8 | 9 | 22 | |||||||||||||||||
Reimbursable expenses | 36 | 31 | 99 | 92 | ||||||||||||||||
Depreciation and amortization expense | 18 | 16 | 51 | 47 | ||||||||||||||||
Equity income from joint ventures | (26) | (36) | (98) | (115) | ||||||||||||||||
Interest | 3 | (1) | 9 | 7 | ||||||||||||||||
Total | 172 | 146 | 483 | 412 | ||||||||||||||||
Income before income tax | 24 | 34 | 159 | 120 | ||||||||||||||||
Income tax expense | (7) | (9) | (44) | (36) | ||||||||||||||||
Net income attributable to Loews Corporation | $ | 17 | $ | 25 | $ | 115 | $ | 84 |
57
|
Three Months Ended | Nine Months Ended | |||||||||||||||||||
September 30, | September 30, | |||||||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||||||
(In millions) | ||||||||||||||||||||
Revenues: | ||||||||||||||||||||
Net investment income (loss) | $ | 31 | $ | (19) | $ | 84 | $ | (100) | ||||||||||||
Operating revenues and other | 4 | 6 | ||||||||||||||||||
Total | 31 | (15) | 84 | (94) | ||||||||||||||||
Expenses: | ||||||||||||||||||||
Operating and other | 69 | 16 | 105 | 58 | ||||||||||||||||
Equity method loss | 4 | 1 | 9 | 4 | ||||||||||||||||
Interest | 18 | 23 | 61 | 67 | ||||||||||||||||
Total | 91 | 40 | 175 | 129 | ||||||||||||||||
Loss before income tax | (60) | (55) | (91) | (223) | ||||||||||||||||
Income tax benefit | 12 | 11 | 15 | 44 | ||||||||||||||||
Net loss attributable to Loews Corporation | $ | (48) | $ | (44) | $ | (76) | $ | (179) |
58
|
59
|
60
|
Three Months Ended | Nine Months Ended | |||||||||||||||||||
September 30, | September 30, | |||||||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||||||
(In millions) | ||||||||||||||||||||
Fixed income securities: | ||||||||||||||||||||
Taxable fixed income securities | $ | 457 | $ | 410 | $ | 1,331 | $ | 1,163 | ||||||||||||
Tax-exempt fixed income securities | 43 | 55 | 138 | 194 | ||||||||||||||||
Total fixed income securities | 500 | 465 | 1,469 | 1,357 | ||||||||||||||||
Limited partnership and common stock investments | 28 | (44) | 124 | (51) | ||||||||||||||||
Other, net of investment expense | 25 | 1 | 60 | (4) | ||||||||||||||||
Net investment income | $ | 553 | $ | 422 | $ | 1,653 | $ | 1,302 |
Effective income yield for the fixed income securities portfolio | 4.7 | % | 4.4 | % | 4.6 | % | 4.3 | % | ||||||||||||
Limited partnership and common stock return | 1.3 | % | (2.1) | % | 5.8 | % | (2.4) | % |
Three Months Ended | Nine Months Ended | |||||||||||||||||||
September 30, | September 30, | |||||||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||||||
(In millions) | ||||||||||||||||||||
Investment gains (losses): | ||||||||||||||||||||
Fixed maturity securities: | ||||||||||||||||||||
Corporate and other bonds | $ | (11) | $ | (41) | $ | (46) | $ | (68) | ||||||||||||
States, municipalities and political subdivisions | (4) | 6 | 3 | 28 | ||||||||||||||||
Asset-backed | (22) | (17) | (43) | (29) | ||||||||||||||||
Total fixed maturity securities | (37) | (52) | (86) | (69) | ||||||||||||||||
Non-redeemable preferred stock | 2 | (2) | (9) | (111) | ||||||||||||||||
Derivatives, short term and other | (3) | (42) | (10) | 14 | ||||||||||||||||
Total investment losses | (38) | (96) | (105) | (166) | ||||||||||||||||
Income tax benefit | 7 | 12 | 21 | 39 | ||||||||||||||||
Amounts attributable to noncontrolling interests | 4 | 8 | 9 | 12 | ||||||||||||||||
Investment losses attributable to Loews Corporation | $ | (27) | $ | (76) | $ | (75) | $ | (115) |
61
|
September 30, 2023
|
December 31, 2022
|
||||||||||||||||||||||
Estimated
Fair Value
|
Net
Unrealized Gains (Losses)
|
Estimated
Fair Value
|
Net
Unrealized Gains
(Losses)
|
||||||||||||||||||||
(In millions) | |||||||||||||||||||||||
U.S. Government, Government agencies and Government-sponsored enterprises | $ | 2,672 | $ | (464) | $ | 2,419 | $ | (336) | |||||||||||||||
AAA | 2,464 | (340) | 2,398 | (208) | |||||||||||||||||||
AA | 5,916 | (950) | 6,342 | (663) | |||||||||||||||||||
A | 9,372 | (772) | 9,043 | (531) | |||||||||||||||||||
BBB | 15,632 | (1,776) | 15,651 | (1,447) | |||||||||||||||||||
Non-investment grade | 1,800 | (190) | 1,774 | (219) | |||||||||||||||||||
Total | $ | 37,856 | $ | (4,492) | $ | 37,627 | $ | (3,404) |
September 30, 2023
|
Estimated
Fair Value
|
Gross Unrealized Losses | |||||||||
(In millions) | |||||||||||
U.S. Government, Government agencies and
Government-sponsored enterprises |
$ | 2,620 | $ | 466 | |||||||
AAA | 1,893 | 382 | |||||||||
AA | 4,458 | 1,037 | |||||||||
A | 7,240 | 913 | |||||||||
BBB | 13,704 | 1,881 | |||||||||
Non-investment grade | 1,202 | 209 | |||||||||
Total | $ | 31,117 | $ | 4,888 |
62
|
September 30, 2023
|
Estimated
Fair Value
|
Gross Unrealized Losses | |||||||||
(In millions) | |||||||||||
Due in one year or less | $ | 953 | $ | 45 | |||||||
Due after one year through five years | 9,059 | 701 | |||||||||
Due after five years through ten years | 9,535 | 1,550 | |||||||||
Due after ten years | 11,570 | 2,592 | |||||||||
Total | $ | 31,117 | $ | 4,888 |
September 30, 2023
|
Estimated
Fair Value
|
Net Unrealized Gains (Losses) | |||||||||
(In millions) | |||||||||||
Commercial mortgage-backed: | |||||||||||
Single asset, single borrower: | |||||||||||
Office | $ | 293 | $ | (83) | |||||||
Retail | 269 | (37) | |||||||||
Lodging | 216 | (23) | |||||||||
Industrial | 91 | (6) | |||||||||
Multifamily | 58 | (4) | |||||||||
Total single asset, single borrower | 927 | (153) | |||||||||
Conduits (multi property, multi borrower pools) | 627 | (119) | |||||||||
Total commercial mortgage-backed | $ | 1,554 | $ | (272) |
63
|
September 30, 2023
|
Estimated
Fair Value
|
Net Unrealized Gains (Losses) | |||||||||
(In millions) | |||||||||||
Commercial mortgage backed: | |||||||||||
AAA | $ | 504 | $ | (39) | |||||||
AA | 578 | (120) | |||||||||
A | 198 | (37) | |||||||||
BBB | 222 | (52) | |||||||||
Non-investment grade | 52 | (24) | |||||||||
Total commercial mortgage-backed | $ | 1,554 | $ | (272) |
September 30, 2023
|
Estimated
Fair Value
|
Net Unrealized Gains (Losses) | |||||||||
(In millions) | |||||||||||
Corporate and other bonds - REITs: | |||||||||||
Retail | $ | 462 | $ | (53) | |||||||
Office | 237 | (32) | |||||||||
Industrial | 83 | (8) | |||||||||
Other (a) | 412 | (41) | |||||||||
Total corporate and other bonds - REITs | $ | 1,194 | $ | (134) |
(a) | Other includes a diversified mix of property type strategies including self-storage, healthcare and apartments. |
September 30, 2023
|
Estimated
Fair Value
|
Net Unrealized Gains (Losses) | |||||||||
(In millions) | |||||||||||
Corporate and other bonds - REITs: | |||||||||||
AA | $ | 10 | $ | (1) | |||||||
A | 244 | (18) | |||||||||
BBB | 918 | (112) | |||||||||
Non-investment grade | 22 | (3) | |||||||||
Total corporate and other bonds - REITs | $ | 1,194 | $ | (134) |
64
|
September 30, 2023
|
Amortized Cost | Percentage of Total | |||||||||
(In millions, except %) | |||||||||||
Mortgage loans: | |||||||||||
Retail | $ | 470 | 45 | % | |||||||
Office | 246 | 24 | |||||||||
Industrial | 133 | 13 | |||||||||
Other | 181 | 18 | |||||||||
Total mortgage loans | 1,030 | 100 | % | ||||||||
Less: Allowance for expected credit losses | (35) | ||||||||||
Total mortgage loans - net of allowance | $ | 995 |
September 30, 2023
|
December 31, 2022
|
||||||||||||||||||||||
Estimated
Fair Value |
Effective Duration (Years) |
Estimated
Fair Value |
Effective Duration (Years) | ||||||||||||||||||||
(In millions of dollars) | |||||||||||||||||||||||
Investments supporting Other Insurance Operations | $ | 13,737 | 9.8 | $ | 14,511 | 9.9 | |||||||||||||||||
Other investments | 26,459 | 4.6 | 25,445 | 4.7 | |||||||||||||||||||
Total | $ | 40,196 | 6.3 | $ | 39,956 | 6.6 |
65
|
66
|
67
|
Period |
(a) Total number
of shares
purchased
|
(b) Average
price paid per
share
|
(c) Total number of shares purchased as
part of publicly announced plans or programs
|
(d) Maximum number of shares (or approximate dollar value)
of shares that may yet be purchased under the plans or programs (in millions)
|
|||||||||||||||||||
July 1, 2023 - July 31, 2023
|
602,446 | $ | 60.19 | N/A | N/A | ||||||||||||||||||
August 1, 2023 - August 31, 2023
|
136,585 | 61.91 | N/A | N/A | |||||||||||||||||||
September 1, 2023 - September 30, 2023
|
1,132,685 | 63.56 | N/A | N/A |
|
Date of Adoption
|
Percentage of Net Shares to Be Sold
|
||||||
|
|
100%
|
||||||
|
|
50%
|
||||||
|
|
100%
|
||||||
|
|
100%
|
||||||
|
|
100%
|
68
|
Description of Exhibit |
Exhibit
Number |
||||
XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document | 101.INS * | ||||
Inline XBRL Taxonomy Extension Schema | 101.SCH * | ||||
Inline XBRL Taxonomy Extension Calculation Linkbase | 101.CAL * | ||||
Inline XBRL Taxonomy Extension Definition Linkbase | 101.DEF * | ||||
Inline XBRL Taxonomy Label Linkbase | 101.LAB * | ||||
Inline XBRL Taxonomy Extension Presentation Linkbase | 101.PRE * | ||||
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) | 104* |
69
|
LOEWS CORPORATION | |||||||||||
(Registrant) | |||||||||||
Dated: October 30, 2023
|
By: | /s/ Jane J. Wang | |||||||||
JANE J. WANG | |||||||||||
Senior Vice President and
Chief Financial Officer (Duly authorized officer and principal financial officer) |
70
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|
No information found
Customers
Customer name | Ticker |
---|---|
Fidelity National Financial, Inc. | FNF |
Suppliers
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|